Correlation Between Editas Medicine and Intellia Therapeutics

Can any of the company-specific risk be diversified away by investing in both Editas Medicine and Intellia Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Editas Medicine and Intellia Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Editas Medicine and Intellia Therapeutics, you can compare the effects of market volatilities on Editas Medicine and Intellia Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Editas Medicine with a short position of Intellia Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Editas Medicine and Intellia Therapeutics.

Diversification Opportunities for Editas Medicine and Intellia Therapeutics

0.18

Correlation Coefficient

Editas Medicine  Intellia Therapeutics

Average diversification

The 3 months correlation between Editas and Intellia is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Editas Medicine and Intellia Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intellia Therapeutics and Editas Medicine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Editas Medicine are associated (or correlated) with Intellia Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intellia Therapeutics has no effect on the direction of Editas Medicine i.e., Editas Medicine and Intellia Therapeutics go up and down completely randomly.

Pair Corralation between Editas Medicine and Intellia Therapeutics

Given the investment horizon of 90 days Editas Medicine is expected to generate 2.7 times more return on investment than Intellia Therapeutics. However, Editas Medicine is 2.7 times more volatile than Intellia Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Intellia Therapeutics is currently generating about -0.09 per unit of risk. If you would invest  120.00  in Editas Medicine on December 29, 2024 and sell it today you would earn a total of  10.00  from holding Editas Medicine or generate 8.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Editas Medicine  vs.  Intellia Therapeutics

Editas Medicine

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Editas Medicine are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating forward indicators, Editas Medicine unveiled solid returns over the last few months and may actually be approaching a breakup point.

Intellia Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Intellia Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's essential indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Editas Medicine and Intellia Therapeutics

The main advantage of trading using opposite Editas Medicine and Intellia Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Editas Medicine position performs unexpectedly, Intellia Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intellia Therapeutics will offset losses from the drop in Intellia Therapeutics' long position.

The idea behind Editas Medicine and Intellia Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.